logo

Breaking News

Share SHARE

Shares of Westar Energy (WR) have moved sharply higher during trading on Tuesday, with the electric utility currently up by 7.5 percent.

After rising sharply at the open, shares of Celator Pharmaceuticals (CPXX) continue to see significant strength in afternoon trading on Tuesday.

The U.S. life insurer Fidelity & Guaranty Life (FGL) said in a regulatory filing that Beijing-based Anbang Insurance Group Co. on May 27 had withdrawn its application with New York's Department of Financial Services for approval of Anbang's pending acquisition of Fidelity & Guaranty Life, after discussion...

The U.S. Food and Drug Administration has approved Jentadueto XR (linagliptin and metformin hydrochloride extended-release) tablets for the treatment of type 2 diabetes or T2D in adults. JENTADUETO XR, which is marketed by Boehringer Ingelheim and Eli Lilly and Co. (LLY), is the seventh new treatment...

MGT Capital Investments Inc. (MGT) provided a commentary from the company's proposed Executive Chairman and Chief Executive Officer, John McAfee. On Sunday afternoon May 29th, McAfee, conceded the Libertarian Party nomination for President of the United States to former New Mexico Governor Gary Johnson....

Diebold Inc. (DBD) announced its planned acquisition of Wincor Nixdorf AG (WNXDF.PK, WNXDY.PK) has recently cleared antitrust requirements from authorities in Portugal, Russia, Slovakia and Spain. Diebold has obtained antitrust clearance in the United States, China, Turkey and Austria. The takeover...

Marketo Inc. (MKTO) said that it agreed to be acquired by Vista Equity Partners, a private equity firm focused on investments in software, data and technology-enabled businesses, for a total value of about $1.79 billion. Marketo shareholders will receive $35.25 in cash per share, representing a 64%...

Regeneron Pharmaceuticals, Inc. (REGN) said that positive preliminary results from an ongoing proof-of-concept study of evinacumab, REGN1500, in patients with Homozygous Familial Hypercholestrolemia or HoFH were presented at the 84th European Atherosclerosis Society (EAS) Congress in Innsbruck, Austria. HoFH...

BioRap Technologies Ltd, the technology transfer company of the Rappaport Institute for Biomedical Research at the Technion - Israel Institute of Technology, has entered into a research collaboration, option and license agreement with Pfizer Inc. (PFE) that aims to further develop a certain monoclonal...

Cliffs Natural Resources Inc. (CLF) said it has entered into a new long-term commercial agreement with ArcelorMittal USA LLC (MT) to supply tailor-made iron ore pellets for the next ten years through 2026. The company noted that the new agreement will replace two existing agreements expiring in December...

Time Inc. (TIME) confirmed reports that Myspace, a Time Inc. company and social networking site, has been the victim of a hacking incident. Shortly before the Memorial Day weekend, the Myspace technical security team became aware that stolen Myspace user login data was being made available in an online...

Vertex Pharmaceuticals Inc. (VRTX) announced that the U.S. Food and Drug Administration has accepted for review a supplemental New Drug Application or sNDA for the use of ORKAMBI or lumacaftor/ivacaftor in people with cystic fibrosis or CF ages 6 to 11 who have two copies of the F508del mutation. The...

Soligenix, Inc. (SNGX.OB), a late-stage biopharmaceutical company focused on rare diseases, announced Tuesday that its SGX943 (dusquetide) development program has received "Fast Track" designation from the US Food and Drug Administration or FDA as adjunctive therapy with other antibacterial drugs, for...

ARIAD Pharmaceuticals Inc. (ARIA) announced initiation of the Phase 1/2 clinical trial of AP32788, an investigational tyrosine kinase inhibitor (TKI) designed as a targeted therapy for patients with non-small cell lung cancer (NSCLC) with specific mutations in EGFR or HER2. AP32788 targets tumors driven...

Biogen Inc. (BIIB) said that the Committee of Medicinal Products for Human Use or CHMP of the European Medicines Agency has adopted a positive opinion recommending approval of a variation to the marketing authorization of Tysabri, or natalizumab. The CHMP has recommended the approval of Tysabri for...

Follow RTT